Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 CAD | 0.00% | +4.76% | -45.00% |
Apr. 25 | FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement | MT |
Apr. 08 | FSD Pharma Receives Nasdaq Non-Compliance Notice | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-45.00% | 19.34M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HUGE Stock
- News FSD Pharma Inc.
- FSD Pharma Brief: Signed Agreement With iNGENu CRO To Conduct a Clinical Study To Assess Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults